MIST — Milestone Pharmaceuticals Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1408443 ·
Last close
$1.40
Market Cap
$174.30M
52W High
$2.34
52W Low
$1.00
ADV30
1,573,076
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 238,000 | 224,000 | -23,663,000 | -26,066,000 | 193,734,000 | 71,317,000 | 157,685,000 |
| Dec 2025 | 1,546,000 | — | -17,257,000 | -17,409,000 | 113,561,000 | 73,046,000 | 71,792,000 |
| Sep 2025 | 0 | — | -11,829,000 | -11,922,000 | 87,750,000 | 46,685,000 | 67,249,000 |
| Jun 2025 | 0 | — | -12,531,000 | -12,966,000 | 47,417,000 | 42,499,000 | 65,162,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-49,041,000
Investing CF
$11,246,000
Financing CF
$85,527,000
CapEx
$-302,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.77
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-430,603,000
Inventory
$648,000
Receivables
$3,508,000
ST Investments
$32,914,000
EBIT TTM
$-59,220,000
Pretax Income TTM
$-63,058,000
Interest Exp TTM
$3,838,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,546,000
EBITDA
$-62,026,000
Free Cash Flow
$-28,903,250
Enterprise Value
$-19,352,768
Total Cash
$105,960,000
Total Debt
$58,377,000
Shares Out
124,497,980
Trailing EPS
$-0.64
Book Value
$0.34
ROE
-229.7%
ROA
-41.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,546,000 | -62,140,000 | -63,058,000 | 113,561,000 | 71,792,000 | — | -49,041,000 |
| Dec 2024 | 0 | -42,102,000 | -41,519,000 | 75,499,000 | 62,352,000 | — | -28,848,000 |
| Dec 2023 | 1,000,000 | -61,098,000 | -59,685,000 | 75,226,000 | 58,455,000 | — | -46,424,000 |
| Dec 2022 | 5,000,000 | -59,642,000 | -58,388,000 | 74,483,000 | 8,135,000 | — | -52,469,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.04
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NGEN | NERVGEN PHARMA CORP. | $175.07M | $2.13 | — |
| IMUX | IMMUNIC, INC. | $176.67M | $12.97 | — |
| KRRO | Korro Bio, Inc. | $177.83M | $12.33 | — |
| ANTX | AN2 Therapeutics, Inc. | $170.36M | $4.73 | — |
| LFCR | LIFECORE BIOMEDICAL, INC. \DE\ | $180.05M | $4.80 | — |
News headlines (Yahoo Finance, 1h cache)
Paroxysmal Supraventricular Tachycardia Market Analysis Report 2026-2036, Profiles of Leading Players - Medtronic, Boston Scientific, Abbott Laboratories, Milestone Pharmaceuticals, Sanofi, Pfizer
2026-05-21 13:00 · Yahoo
Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) Path To Profitability
2026-05-15 10:49 · Yahoo
Milestone Pharmaceuticals to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
2026-05-14 12:30 · Yahoo
Milestone Pharmaceuticals Inc. Q1 2026 Earnings Call Summary
2026-05-14 00:44 · Yahoo
Milestone Pharmaceuticals Inc (MIST) Q1 2026 Earnings Call Highlights: Strategic Advances Amid ...
2026-05-13 23:00 · Yahoo
Why Milestone Pharmaceuticals Stock Wilted on Wednesday
2026-05-13 22:16 · Yahoo
Milestone Pharmaceuticals Q1 Earnings Call Highlights
2026-05-13 18:09 · Yahoo
Milestone Pharmaceuticals Q1 2026 Earnings Call: Complete Transcript
2026-05-13 13:40 · Yahoo
Milestone Pharmaceuticals shares plunge after CARDAMYST revenue misses expectations (MIST)
2026-05-13 13:34 · Yahoo
Milestone Pharmaceuticals (MIST) Reports Q1 Loss, Lags Revenue Estimates
2026-05-13 12:20 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.